Live Breaking News & Updates on Hr positive breast cancer

Stay updated with breaking news from Hr positive breast cancer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

The Role of Elacestrant in Breast Cancer

Erica L. Mayer, MD, MPH, discusses the role of elacestrant in the breast cancer treatment landscape and provides clinical insights on its safety profile. ....

Erical-mayer , Breast-cancer , Hr-breast-cancer , Hr-positive-breast-cancer , Breast-cancer-treatment , Esr1 , Esr1-mutations , Elacestrant , Endocrine-therapies , Emerald-study , Emerald-trial

SERENA-2: Camizestrant vs Fulvestrant in Advanced ER+/HER2- Breast Cancer

Medical oncologists discuss oral SERDs, with a focus on the SERENA-2 trial looking at camizestrant in patients with advanced ER+/HER2- breast cancer. ....

Breast-cancer , Hr-breast-cancer , Hr-positive-breast-cancer , Breast-cancer-treatment , Esr1 , Esr1-mutations , Oral-serds , Serds , Serena-2 , Adverse-effects , Camizestrant

PADA-1 Trial: ctDNA Monitoring for Acquired ESR1 Mutations in Advanced Breast Cancer

Drs Mayer and Kalinsky provide insights and offer their impressions of the PADA-1 trial, focusing on ESR1 mutation monitoring with circulating tumor DNA (ctDNA). ....

Breast-cancer , Advanced-breast , Hr-breast-cancer , Hr-positive-breast-cancer , Breast-cancer-treatment , Esr1 , Esr1-mutations , Biomarker-testing , Esr1-testing , Pada-1 , Ctdna

EMERALD: Elacestrant in ER+/HER2- Advanced Breast Cancer

Kevin Kalinsky, MD, MS, gives an overview of recent data from the EMERALD trial investigating elacestrant in patients with ER+/HER2- advanced breast cancer. ....

Kevin-kalinsky , Breast-cancer , Hr-breast-cancer , Hr-positive-breast-cancer , Breast-cancer-treatment , Esr1 , Esr1-mutations , Emerald-study , Emerald-trial , Elacestrant ,

Testing for ESR1 Mutations in Breast Cancer

Kevin Kalinsky, MD, MS, and Erica L. Mayer, MD, MPH, discuss testing practices for ESR1 mutations in patients with breast cancer. ....

Erical-mayer , Kevin-kalinsky , Breast-cancer , Hr-breast-cancer , Hr-positive-breast-cancer , Breast-cancer-treatment , Esr1 , Esr1-mutations , Biomarker-testing , Esr1-testing , Asco-recommendations